How are you selecting between oral therapies and parenteral treatments for managing hereditary angioedema attacks?
Do you always choose one or the other? Or are certain patient factors guiding your decision?
Answer from: at Community Practice
I use shared decision making by explaining the route of therapy, how often the medicine is given, the efficacy, and the side effects of the medications and allow the patient to decide what drug they would prefer.